Related Experiment Video
Updated: May 2, 2026
09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
8.8K
Hepatoprotective effects of triterpenoids from Ganoderma cochlear
Xing-Rong Peng1, Jie-Qing Liu, Cui-Fang Wang
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Science , Kunming 650201, People's Republic of China.
Journal of Natural Products
|February 25, 2014
Summary
Researchers discovered new triterpenoids from Ganoderma cochlear, with some showing potential hepatoprotective effects by lowering liver enzyme levels in cell models.
Area of Science:
- Natural Product Chemistry
- Pharmacology
Background:
- Ganoderma species are known sources of bioactive triterpenoids.
- Investigating novel compounds from medicinal mushrooms is crucial for drug discovery.
Purpose of the Study:
- To isolate and characterize novel triterpenoids from Ganoderma cochlear.
- To evaluate the potential hepatoprotective activity of isolated compounds.
Main Methods:
- Isolation and purification of compounds using chromatographic techniques.
- Structural elucidation via comprehensive spectroscopic analysis (NMR, MS).
- X-ray crystallographic analysis for definitive structure confirmation.
- In vitro assays using HepG2 cells to assess hepatoprotective effects against H2O2-induced damage.
Main Results:
- Two novel trinorlanostanes (cochlates A and B) and six new triterpenoids (fornicatins D-F, ganodercochlearins A-C) were identified.
- Five known triterpenoids were also isolated.
- Compounds fornicatins A, D, F, and fredelin demonstrated a significant reduction in ALT and AST levels in treated HepG2 cells.
Conclusions:
- Ganoderma cochlear is a rich source of structurally diverse triterpenoids.
- Specific triterpenoids, including fornicatins A, D, F, and fredelin, exhibit promising hepatoprotective properties.
- These findings suggest potential therapeutic applications for these compounds in liver protection.
